These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The many effects of lactulose: a rational approach to its therapeutic use. Bircher J Drugs; 1972; 4(1):1-3. PubMed ID: 4637574 [No Abstract] [Full Text] [Related]
5. [Hepatic encephalopathy and its therapy with lactulose]. Pericoli F Policlinico Prat; 1971 Jun; 78(12):509-14. PubMed ID: 5568016 [No Abstract] [Full Text] [Related]
6. [Use of lactulose in the treatment of porto-systemic encephalopathy and chronic constipation]. Azzena D; Arfini G; Melli E Recenti Prog Med; 1972 Mar; 52(3):273-84. PubMed ID: 5067694 [No Abstract] [Full Text] [Related]
7. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy. Zeegen R; Drinkwater JE; Fenton JC; Vince A; Dawson AM Q J Med; 1970 Apr; 39(154):245-63. PubMed ID: 5449591 [No Abstract] [Full Text] [Related]
8. Lactulose (Chronulac) for constipation. Med Lett Drugs Ther; 1980 Jan; 22(1):2-4. PubMed ID: 6986542 [No Abstract] [Full Text] [Related]
9. Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy. Avery GS; Davies EF; Brogden RN Drugs; 1972; 4(1):7-48. PubMed ID: 4564869 [No Abstract] [Full Text] [Related]
10. [Intestine and liver-protective therapy]. Kremer H Z Allgemeinmed; 1974 Oct; 50(28):1252-5. PubMed ID: 4446643 [No Abstract] [Full Text] [Related]
11. [Ileus-like symptoms following lactulose]. Wewalka F Wien Z Inn Med; 1972; 53(6):321-2. PubMed ID: 5086492 [No Abstract] [Full Text] [Related]
12. [Efficiency and tolerance of lactulose in constipation in pregnant women]. Lachgar M; Morer I Rev Fr Gynecol Obstet; 1985; 80(8-9):663-5. PubMed ID: 4059779 [No Abstract] [Full Text] [Related]
13. [Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy]. Fortschr Med; 1982 Nov; 100(44):2059-60. PubMed ID: 7173786 [No Abstract] [Full Text] [Related]
14. [Treatment with lactulose. A low-risk alternative in various diseases]. Reim HG; Koken M Fortschr Med; 1984 Dec; 102(45):1167-70. PubMed ID: 6394457 [No Abstract] [Full Text] [Related]
16. Some observations of the use of lactulose in the treatment of obstipation in geriatric patients. Kahanpää A Geron; 1974-1975; (20):79-86. PubMed ID: 4468219 [No Abstract] [Full Text] [Related]
18. Lactulose: comments on mechanism of action and current status. Conn HO Conn Med; 1972 Oct; 36(10):582-6. PubMed ID: 5086118 [No Abstract] [Full Text] [Related]
19. [Lactulose treatment in three patients with chronic portal-systemic encephalopathy]. Tamai Y; Iwata Y; Tsuji M; Minakuchi C; Nagakawa J Naika Hokan; 1972 Apr; 19(4):113-8. PubMed ID: 5065961 [No Abstract] [Full Text] [Related]
20. Lactulose in the treatment of acute and chronic hepatic encephalopathy. Fung WP; Khoo OT Singapore Med J; 1971 Jun; 12(3):176-80. PubMed ID: 5094427 [No Abstract] [Full Text] [Related] [Next] [New Search]